Cytokinetics (CYTK) Misses Q1 EPS by 2c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $79.17 +0.50%
Revenue Growth %: -75.4%
Financial Fact:
Research and development: 19.34M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -75.4%
Financial Fact:
Research and development: 19.34M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q1 EPS of ($1.67), $0.02 worse than the analyst estimate of ($1.65). Revenue for the quarter came in at $19.35 million versus the consensus estimate of $8.59 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- S&P Global (SPGI) Declares $0.97 Quarterly Dividend; 1% Yield
- MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
